Eliana Merle
Stock Analyst at Barclays
(3.46)
# 2,275
Out of 4,574 analysts
378
Total ratings
46.2%
Success rate
3.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintained: Hold | $48 | $54.07 | -11.23% | 30 | Jul 24, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $527 | $271.77 | +93.91% | 15 | Jul 23, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $105 | $59.33 | +76.98% | 40 | Jul 23, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $90 | $56.55 | +59.15% | 21 | Jul 23, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $120 | $76.82 | +56.21% | 12 | Jul 21, 2026 | |
| INSM Insmed | Maintained: Buy | $237 | $106.92 | +121.66% | 7 | Jul 17, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintained: Buy | $964 | $544.51 | +77.04% | 14 | Jul 13, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $157 | $84.02 | +86.86% | 19 | Jul 9, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $615 | $477.36 | +28.83% | 14 | Jul 8, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $345 | $253.86 | +35.90% | 12 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.51 | +270.37% | 1 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $15.68 | +27.55% | 11 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $65 | $38.97 | +66.79% | 12 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $133 | $110.57 | +20.29% | 11 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $62.00 | +12.90% | 5 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $4.46 | +303.59% | 4 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 | $30.63 | +92.62% | 8 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $917 | $656.01 | +39.78% | 3 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.3 → $0.28 | $0.136 | +105.88% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $12 | $9.73 | +23.33% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $2.77 | +622.02% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $26.90 | +59.85% | 5 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $7.07 | +13.15% | 4 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $10.07 | +227.71% | 1 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $115 → $117 | $89.33 | +30.98% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 → $20 | $54.15 | -63.07% | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 → $112 | $129.31 | -13.39% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $85.60 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.50 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $21 | $8.03 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $2.2 | $4.33 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 | $189.23 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $41.41 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $22.78 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $7.88 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $192 → $134 | $27.84 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $1.72 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.71 | n/a | 4 | Mar 18, 2019 |
Moderna
Jul 24, 2026
Maintained: Hold
Price Target: $48
Current: $54.07
Upside: -11.23%
Alnylam Pharmaceuticals
Jul 23, 2026
Maintained: Buy
Price Target: $527
Current: $271.77
Upside: +93.91%
BioMarin Pharmaceutical
Jul 23, 2026
Maintained: Buy
Price Target: $105
Current: $59.33
Upside: +76.98%
Ionis Pharmaceuticals
Jul 23, 2026
Maintained: Buy
Price Target: $90
Current: $56.55
Upside: +59.15%
PTC Therapeutics
Jul 21, 2026
Maintained: Buy
Price Target: $120
Current: $76.82
Upside: +56.21%
Insmed
Jul 17, 2026
Maintained: Buy
Price Target: $237
Current: $106.92
Upside: +121.66%
Madrigal Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $964
Current: $544.51
Upside: +77.04%
BridgeBio Pharma
Jul 9, 2026
Reiterated: Buy
Price Target: $157
Current: $84.02
Upside: +86.86%
Vertex Pharmaceuticals
Jul 8, 2026
Maintained: Buy
Price Target: $615
Current: $477.36
Upside: +28.83%
Ascendis Pharma
Jul 8, 2026
Maintained: Buy
Price Target: $345
Current: $253.86
Upside: +35.90%
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $3.51
Upside: +270.37%
Jun 22, 2026
Maintained: Hold
Price Target: $20
Current: $15.68
Upside: +27.55%
Jun 22, 2026
Upgraded: Buy
Price Target: $65
Current: $38.97
Upside: +66.79%
Jun 22, 2026
Maintained: Buy
Price Target: $133
Current: $110.57
Upside: +20.29%
Jun 15, 2026
Maintained: Buy
Price Target: $70
Current: $62.00
Upside: +12.90%
Jun 4, 2026
Maintained: Buy
Price Target: $18
Current: $4.46
Upside: +303.59%
Jun 3, 2026
Maintained: Buy
Price Target: $59
Current: $30.63
Upside: +92.62%
May 18, 2026
Maintained: Buy
Price Target: $917
Current: $656.01
Upside: +39.78%
May 18, 2026
Maintained: Sell
Price Target: $0.3 → $0.28
Current: $0.136
Upside: +105.88%
May 15, 2026
Maintained: Buy
Price Target: $37 → $12
Current: $9.73
Upside: +23.33%
May 14, 2026
Maintained: Buy
Price Target: $20
Current: $2.77
Upside: +622.02%
May 6, 2026
Maintained: Buy
Price Target: $43
Current: $26.90
Upside: +59.85%
Apr 2, 2026
Maintained: Hold
Price Target: $8
Current: $7.07
Upside: +13.15%
Jan 27, 2026
Maintained: Buy
Price Target: $33
Current: $10.07
Upside: +227.71%
Nov 6, 2025
Maintained: Hold
Price Target: $115 → $117
Current: $89.33
Upside: +30.98%
Aug 12, 2025
Maintained: Hold
Price Target: $33 → $20
Current: $54.15
Upside: -63.07%
Aug 8, 2025
Maintained: Hold
Price Target: $96 → $112
Current: $129.31
Upside: -13.39%
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $85.60
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: $8
Current: $1.50
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: $74 → $21
Current: $8.03
Upside: n/a
Jan 28, 2025
Maintained: Hold
Price Target: $5 → $2.2
Current: $4.33
Upside: n/a
Jan 8, 2025
Maintained: Buy
Price Target: $71
Current: $189.23
Upside: n/a
Apr 4, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $41.41
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $22.78
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $7.88
Upside: n/a
Aug 19, 2020
Maintained: Hold
Price Target: $192 → $134
Current: $27.84
Upside: n/a
Dec 11, 2019
Maintained: Buy
Price Target: $40
Current: $1.72
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $3.71
Upside: n/a